MBX Biosciences Common Stock (MBX) Cash From Financing

Annual CFF

$69.22 M
+$23.16 M+50.27%

01 December 2023

All-time High

$69.22 M
MBX annual cash flow from financing activities is currently at an all-time high
Annual CFI-$30.93 M
MBX annual cash flow from investing activities is -$30.93 million
Annual CFO-$31.98 M
MBX annual cash flow from operations is -$31.98 million
Annual FCF-$32.11 M
MBX annual free cash flow is -$32.11 million

MBX Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFF

$235.81 M
0.00%

30 September 2024

All-time High

$235.81 M
MBX quarterly cash flow from financing activities is currently at an all-time high
Quarterly CFI-$100.79 M
MBX quarterly cash flow from investing activities is -$100.79 million
Quarterly CFO-$14.66 M
MBX quarterly cash flow from operations is -$14.66 million
Quarterly FCF-$14.72 M
MBX quarterly free cash flow is -$14.72 million
Quarterly CAPEX$57.00 K
MBX quarterly capital expenditures is $57.00 thousand

MBX Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFF

$235.81 M
0.00%

30 September 2024

All-time High

$235.81 M
MBX TTM cash flow from financing activities is currently at an all-time high
TTM CFI-$100.79 M
MBX TTM cash flow from investing activities is -$100.79 million
TTM CFO-$14.66 M
MBX TTM cash flow from operations is -$14.66 million
TTM FCF-$14.72 M
MBX TTM free cash flow is -$14.72 million
TTM CAPEX$57.00 K
MBX TTM capital expenditures is $57.00 thousand

MBX TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MBX Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

MBX Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat highat highat high

MBX Biosciences Common Stock Cash From Financing History

DateAnnualQuarterlyTTM
Sept 2024
-
$235.81 M(+244.3%)
$235.81 M(+244.3%)
Dec 2023
$69.22 M
-
-
DateAnnualQuarterlyTTM
Sept 2023
-
$68.50 M
$68.50 M
Dec 2022
$46.06 M
-
-

FAQ

  • What is MBX Biosciences Common Stock annual cash flow from financing activities?
  • What is the all time high annual CFF for MBX Biosciences Common Stock?
  • What is MBX Biosciences Common Stock quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for MBX Biosciences Common Stock?
  • What is MBX Biosciences Common Stock TTM cash flow from financing activities?
  • What is the all time high TTM CFF for MBX Biosciences Common Stock?

What is MBX Biosciences Common Stock annual cash flow from financing activities?

The current annual CFF of MBX is $69.22 M

What is the all time high annual CFF for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high annual cash flow from financing activities is $69.22 M

What is MBX Biosciences Common Stock quarterly cash flow from financing activities?

The current quarterly CFF of MBX is $235.81 M

What is the all time high quarterly CFF for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high quarterly cash flow from financing activities is $235.81 M

What is MBX Biosciences Common Stock TTM cash flow from financing activities?

The current TTM CFF of MBX is $235.81 M

What is the all time high TTM CFF for MBX Biosciences Common Stock?

MBX Biosciences Common Stock all-time high TTM cash flow from financing activities is $235.81 M